Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
Clinical trial NCT05416476 · UNKNOWN
Trial details
- NCT number
- NCT05416476
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2025-10-30
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.